![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for](https://pbs.twimg.com/media/HHFQZHUbgAAcwgn.jpg)
eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for
EUR27.80
EUR60.80
Pay in 4 interest-free payments of $6.95 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3864614363235387532)
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for](https://substackcdn.com/image/fetch/$s_!x2MN!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc6422889-fc19-436d-8b42-a084661851dd_1200x1200.png)
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for](https://i.ytimg.com/vi/WwoF62V1Lg0/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLAG0Vb3CsA3ma0wwzyQS75Gai3Q-Q)
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for](https://media.licdn.com/dms/image/v2/D5622AQGEFfIjSVR8NA/feedshare-shrink_800/feedshare-shrink_800/0/1721934246108?e=2147483647&v=beta&t=ym_Ev4H6w_6OMP8kZ2OxWL-6Wi9e7shQSIU5dLXuPUI)
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for](https://substackcdn.com/image/fetch/$s_!q2fE!,f_auto,q_auto:best,fl_progressive:steep/https%3A%2F%2Ferictopol.substack.com%2Fapi%2Fv1%2Fpost_preview%2F138773822%2Ftwitter.jpg%3Fversion%3D4)
